Key result
Dynamic cardiomyoplasty in 78 patients with severe heart failure showed clinical functional improvement and low perioperative mortality over an average implant time of 11.7 months.
Why the study?
Does dynamic cardiomyoplasty improve functional status and survival in patients with severe cardiac insufficiency?
Observational (n=78)
Yes
Does dynamic cardiomyoplasty improve functional status and survival in patients with severe cardiac insufficiency?
Answers are grounded in this paper and cite their sources.
Dynamic cardiomyoplasty is a feasible procedure that improves functional status in patients with severe heart failure, though its hemodynamic benefits require further study.
From 1985 to April 1990, 78 clinical dynamic cardiomyoplasty procedures were performed using the latissimus dorsi muscle stimulated with the Medtronic Cardiomyoplasty System. Indications for surgery were mostly ischemic and idiopathic dilated cardiomyopathies with patients in severe cardiac insufficiency (NYHA Class III and IV). Results of this multicenter study (11 centers) indicate that the dynamic cardiomyoplasty procedure can be transferred and reproduced in many centers with low perioperative mortality and that it improves the functional status of patients who survive the procedure. The survival rate suggests a long-term benefit (average implant time: 11.7 months). Although clinical functional improvement was reported, actual hemodynamic augmentations could not be clearly demonstrated under the protocol. Further studies of functional and hemodynamic parameters are necessary to determine if dynamic cardiomyoplasty is efficacious for a well-defined group of congestive heart failure patients. These points will be addressed in forthcoming studies.
No takes yet. Share an insight, caveat, or question.
Grandjean et al. (1991) conducted an observational in Severe cardiac insufficiency (NYHA Class III and IV) (n=78). Dynamic cardiomyoplasty was evaluated. Dynamic cardiomyoplasty in 78 patients with severe heart failure showed clinical functional improvement and low perioperative mortality over an average implant time of 11.7 months.
Synapse has enriched 10 related papers. Consider them for comparative context: